Abstract |
We evaluated the antiemetic effect of zacopride, a potent 5-HT3-receptor antagonist with 5-HT4-receptor agonist properties, on delayed emesis caused by cisplatin (5 mg/kg, i.p.) in ferrets, compared with granisetron, a selective 5-HT3-receptor antagonist. Multiple intravenous injections of zacopride at 1 mg/kg, a dose that completely inhibited acute emesis caused bycisplatin (10 mg/kg, i.v.), significantly reduced delayed emesis. Granisetron (3.2 mg/kg) also reduced delayed emesis but this failed to reach statistical significance. The present study suggests that a combined 5-HT3-receptor antagonist/ 5-HT4-receptor agonist, like zacopride, may be useful against both acute and delayed emesis induced by cancer chemotherapy.
|
Authors | Hisashi Yamakuni, Hiroe Nakayama, Shigeo Matsui, Katsunori Imazumi, Masahiko Matsuo, Seitaro Mutoh |
Journal | Journal of pharmacological sciences
(J Pharmacol Sci)
Vol. 101
Issue 1
Pg. 99-102
(May 2006)
ISSN: 1347-8613 [Print] Japan |
PMID | 16651699
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Antiemetics
- Antineoplastic Agents
- Benzamides
- Bridged Bicyclo Compounds, Heterocyclic
- Serotonin Antagonists
- zacopride
- Cisplatin
- Granisetron
|
Topics |
- Animals
- Antiemetics
(pharmacology)
- Antineoplastic Agents
(adverse effects)
- Benzamides
(pharmacology)
- Bridged Bicyclo Compounds, Heterocyclic
(pharmacology)
- Cisplatin
(adverse effects)
- Drug Therapy, Combination
- Ferrets
- Granisetron
(pharmacology)
- Male
- Serotonin Antagonists
(pharmacology)
- Time Factors
- Vomiting
(chemically induced, prevention & control)
|